{"id":"https://openalex.org/W3129015983","doi":"https://doi.org/10.1097/01.qai.0000235624.54265.2a","title":"IMMUNE THERAPEUTICS IN THE HAART ERA; HOW SHOULD THEY BE TESTED IN CLINICAL TRIALS","display_name":"IMMUNE THERAPEUTICS IN THE HAART ERA; HOW SHOULD THEY BE TESTED IN CLINICAL TRIALS","publication_year":2006,"publication_date":"2006-07-01","ids":{"openalex":"https://openalex.org/W3129015983","doi":"https://doi.org/10.1097/01.qai.0000235624.54265.2a","mag":"3129015983"},"language":"en","primary_location":{"id":"doi:10.1097/01.qai.0000235624.54265.2a","doi":"https://doi.org/10.1097/01.qai.0000235624.54265.2a","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.qai.0000235624.54265.2a","pdf_url":null,"source":{"id":"https://openalex.org/S157460402","display_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","issn_l":"1525-4135","issn":["1525-4135","1944-7884"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5107834622","display_name":"David A. Cooper","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"David A. Cooper","raw_affiliation_strings":["National Centre in HIV Epidemiology and Clinical Research, Sydney, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Centre in HIV Epidemiology and Clinical Research, Sydney, Australia","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5107834622"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.2864851,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"42","issue":"3","first_page":"S13","last_page":"S14"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/therapeutic-hiv-vaccine","display_name":"therapeutic HIV vaccine","score":0.8360000252723694},{"id":"https://openalex.org/keywords/hiv-infection","display_name":"HIV infection","score":0.4429999887943268},{"id":"https://openalex.org/keywords/highly-active-antiretroviral-therapy","display_name":"highly active antiretroviral therapy","score":0.8769999742507935},{"id":"https://openalex.org/keywords/clinical-trial-design","display_name":"clinical trial design","score":0.7620000243186951},{"id":"https://openalex.org/keywords/vaccine-adjuvants","display_name":"vaccine adjuvants","score":0.9210000038146973},{"id":"https://openalex.org/keywords/treatment-interruption","display_name":"treatment interruption","score":0.4779999852180481},{"id":"https://openalex.org/keywords/immune-reconstitution","display_name":"immune reconstitution","score":0.414000004529953}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6737400889396667},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6396228671073914},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.6232537031173706},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.6144224405288696},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6004068851470947},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.5669169425964355},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4809757471084595},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.408267080783844},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1360328495502472}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1097/01.qai.0000235624.54265.2a","doi":"https://doi.org/10.1097/01.qai.0000235624.54265.2a","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.qai.0000235624.54265.2a","pdf_url":null,"source":{"id":"https://openalex.org/S157460402","display_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","issn_l":"1525-4135","issn":["1525-4135","1944-7884"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2058818799","https://openalex.org/W2064529761","https://openalex.org/W2089825402","https://openalex.org/W2008864497","https://openalex.org/W2153142947","https://openalex.org/W2161279862","https://openalex.org/W2810153492","https://openalex.org/W2037788334","https://openalex.org/W2007575894","https://openalex.org/W2000429893"],"abstract_inverted_index":{"The":[0,291,720,916],"second":[1],"day":[2],"of":[3,12,47,135,140,150,257,264,274,300,303,309,324,403,406,416,481,500,509,523,530,547,576,581,588,604,606,618,621,751,811,818,821,842,860,931],"the":[4,13,57,74,156,215,255,269,307,312,321,401,404,414,427,545,548,554,609,624,749,760,807,851,858,872],"meeting":[5],"was":[6,398,654,880],"opened":[7],"up":[8],"with":[9,77,525,662,672,689,768,823],"an":[10,716,911],"overview":[11],"current":[14],"state-of-the-art":[15],"clinical":[16,216,439,593,647],"trial":[17,648],"design,":[18],"regulatory":[19,227,418],"needs,":[20],"and":[21,54,67,93,103,122,153,159,191,203,254,285,296,317,320,328,356,366,372,380,461,490,528,558,592,630,695,713,748,785,815,826,867,913,925],"future":[22,803],"challenges":[23],"in":[24,41,268,345,352,376,391,466,474,574,633,730,759,890,922],"vaccine":[25,310,408,452,541,555,678,789,808,904],"development.":[26,422],"He":[27],"stated":[28],"that":[29,883],"although":[30],"highly":[31],"active":[32],"antiretroviral":[33],"therapy":[34,666],"(HAART)":[35],"is":[36,166,218,266,413,424,446,459,495,885,906],"considered":[37],"a":[38,167,301,407,417,447,451,478,631,669,782,797,838,887,928],"major":[39,411],"breakthrough":[40],"HIV":[42,109,120,222],"treatment,":[43],"we":[44,68],"are":[45,61,96,111,200,350,464,571],"aware":[46],"its":[48],"disadvantages":[49],"(ie,":[50,282,611,626,676],"toxicity,":[51],"lifelong":[52],"regimens,":[53,66],"costs).":[55],"On":[56],"flip":[58],"side,":[59],"there":[60,199,332,445,884],"now":[62],"some":[63],"less":[64,178,584,607],"toxic":[65],"should":[69,430,722,793],"be":[70,172,194,238,247,260,499,723,779,794,848],"able":[71],"to":[72,105,113,155,235,453,505,513,553,640,668,686,711,727,739,744,778,781,856,870,876],"address":[73,506],"cost":[75,256,263],"issue":[76,412],"generic":[78,644],"competition.":[79],"Moreover,":[80,331],"studies":[81,470,661],"on":[82,344,400,438,473,488,664,700,707,774],"treatment":[83,718,800],"interruption":[84],"have":[85,187,250,277,293,477,486,537],"also":[86,498,503,538,847],"been":[87,279,294,487],"launched":[88],"(SMART,":[89],"ie,":[90],"CD4+":[91,442,462],"driven),":[92],"pharmaceutical":[94],"companies":[95],"very":[97,211,342,839,907],"actively":[98],"searching":[99],"for":[100,210,220,229,420,450,599,614,638,646,656,693,725,753,895],"new":[101],"drugs":[102],"classes":[104],"cover":[106],"resistance.":[107],"Therapeutic":[108,164],"vaccines":[110,186,601],"designed":[112],"modulate":[114],"host":[115,337,353],"factors,":[116],"which":[117,127,276],"can":[118],"control":[119,575],"replication":[121],"immune":[123,157,233,315,338,865],"deficiency.":[124],"Mechanisms":[125],"by":[126,796],"therapeutic":[128],"vaccination":[129,165,524,812,822,869],"may":[130,171,205,237,241,246,259,333,476,497,846],"work":[131,206],"include":[132,431,602,765],"increased":[133,160],"clearance":[134],"circulating":[136],"virus,":[137],"enhanced":[138],"recognition":[139],"virus":[141],"variants,":[142,862],"improved":[143],"effector":[144],"cell":[145,590],"repertoire,":[146],"more":[147,622],"efficient":[148],"presentation":[149],"viral":[151,457,492,510],"antigens":[152],"adjuvant":[154,531],"system,":[158],"regional":[161],"T-cell":[162],"help.":[163],"novel":[168],"approach;":[169],"it":[170],"HAART":[173,270,489,582,637],"sparing.":[174],"An":[175],"injection":[176],"at":[177],"frequent":[179],"intervals":[180],"would":[181,193],"promote":[182],"adherence.":[183],"In":[184,224,902],"general,":[185],"good":[188],"safety":[189,694],"profiles,":[190],"they":[192,204],"cheaper":[195],"per":[196],"dose.":[197],"However,":[198],"no":[201,226,703],"precedents,":[202],"only":[207],"or":[208,433,441,521,532,583,635,658,680,684,775,899],"better":[209,465,479],"early":[212,343,472,659],"disease":[213],"while":[214],"need":[217,449,504],"clearly":[219],"chronic":[221,455],"infection.":[223],"addition,":[225],"framework":[228,419],"their":[230,421],"development":[231,265,804,905],"exists,":[232],"response":[234],"vectors":[236],"problematic,":[239],"resistance":[240],"develop,":[242],"unknown":[243,267],"immunomodulatory":[244],"effects":[245],"discovered,":[248],"injectables":[249],"adherence":[251],"issues":[252,536],"also,":[253],"goods":[258],"low,":[261],"but":[262,360,393,563,909],"era.":[271],"A":[272,374,756],"number":[273],"studies,":[275],"recently":[278],"carried":[280],"out":[281,715],"Quest,":[283],"Virax,":[284],"ANRS":[286],"093),":[287],"were":[288,650,831],"briefly":[289],"reviewed.":[290],"results":[292],"limited":[295],"confusing":[297],"probably":[298],"because":[299],"combination":[302],"factors":[304],"such":[305,853],"as":[306,854],"lack":[308,415],"potency,":[311],"discordance":[313],"between":[314,828],"effect":[316],"virologic":[318,746],"outcome,":[319],"ambiguous":[322],"role":[323],"adjuvants,":[325],"cytokine":[326,533],"enhancement,":[327],"innate":[329,900],"immunity.":[330,901],"exist":[334],"irreversible":[335],"HIV-induced":[336],"defects.":[339],"For":[340],"example,":[341],"infection,":[346,456],"reduced":[347],"perforin-expressing":[348],"T-cells":[349],"noted":[351],"lymphoid":[354,377,382],"tissue,":[355],"CD4/CCR5":[357],"cells":[358,389],"proliferate":[359,390],"do":[361,394],"not":[362,395,564],"accumulate":[363],"(Figs.":[364],"20":[365],"21).FIGURE":[367],"20:":[368],"Current":[369,386],"state-of-the-art.":[370,387],"Perforin+":[371],"granzyme":[373],"expression":[375],"tissue":[378,383],"(LT)":[379],"gut-associated":[381],"(GALT).FIGURE":[384],"21:":[385],"CD4+CCR5+":[388],"PHI":[392],"accumulate.The":[396],"emphasis":[397],"put":[399],"complexity":[402],"design":[405,649],"study.":[409],"One":[410],"It":[423,653,879],"unclear":[425],"whether":[426,491,894],"patient":[428],"population":[429],"acute":[432,657],"chronically":[434],"infected":[435],"patients":[436,485,663,767],"based":[437,706],"assessment":[440],"nadir.":[443],"Although":[444],"greater":[448,771],"treat":[454],"diversity":[458],"less,":[460],"responses":[463,697],"primary":[467],"infection;":[468],"thus,":[469],"conducted":[471],"infection":[475,660],"chance":[480],"success.":[482],"How":[483],"long":[484],"load":[493],"(VL)":[494],"suppressed":[496],"importance.":[501],"We":[502],"what":[507],"sort":[508],"sequences,":[511],"clades":[512],"use,":[514],"repeated":[515],"single-vector":[516],"dosing,":[517],"prime":[518,682],"boost":[519,712],"strategies":[520,790,845],"order":[522,820],"multiple":[526,824],"vectors,":[527,825],"timing":[529],"enhancement.":[534],"Safety":[535],"slowed":[539],"development;":[540],"developers":[542],"must":[543],"consider":[544],"size":[546],"dose,":[549,809],"reactogenicity,":[550],"preexisting":[551],"antibody":[552],"vector,":[556],"autoimmunity":[557],"adverse":[559],"immunoregulation,":[560],"and,":[561],"last":[562],"least,":[565],"surrogate":[566,892],"marker":[567],"measurement.":[568],"Regulatory":[569],"agencies":[570],"most":[572],"interested":[573],"VL,":[577],"safety,":[578],"delayed":[579],"initiation":[580],"overall":[585],"therapy,":[586,777],"maintenance":[587,603,617],"CD4":[589,619,628,769],"counts,":[591],"end":[594,597,690],"points.":[595],"Worthwhile":[596],"points":[598],"first-generation":[600],"VL":[605],"than":[608,623,772],"threshold":[610,625],"<1000-10,000":[612],"copies":[613],"6-12":[615],"months),":[616],"count":[620],">200-350":[627],"cells/\u03bcL),":[629],"delay":[632],"instituting":[634],"restarting":[636],"6":[639],"12":[641],"months.":[642],"Some":[643],"schemes":[645],"then":[651,710],"presented.":[652],"recommended,":[655],"suppressive":[665],"randomized":[667,780],"placebo":[670,783],"arm":[671,784],"2":[673],"study":[674,721],"arms":[675],"different":[677,681,788],"candidates":[679],"boosts":[683],"dosage),":[685],"receive":[687],"immunization":[688,855,863],"point":[691],"checkpoints":[692],"immunologic":[696,708],"(not":[698],"powered":[699,724],"immunogenicity,":[701],"thus":[702],"stopping":[704],"rule":[705],"response),":[709],"carry":[714],"analytical":[717,799],"interruption.":[719,801],"0.5-":[726],"1.0-log":[728],"differences":[729],"VLs.":[731],"This":[732],"strategy":[733],"involves":[734],"many":[735],"decisions":[736],"regarding":[737],"how":[738,742],"handle":[740],"noncompliance,":[741],"often":[743],"monitor":[745],"parameters,":[747],"establishment":[750],"rules":[752],"reinstating":[754],"therapy.":[755],"possible":[757],"scheme":[758],"phase":[761],"III":[762],"setting":[763],"could":[764],"asymptomatic":[766],"counts":[770],"500,":[773],"off":[776],"once":[786],"again":[787],"arms.":[791],"Vaccination":[792],"followed":[795,920],"longer":[798],"Last,":[802],"challenges,":[805],"including":[806],"route":[810],"(subcutaneous,":[813],"intramuscular,":[814],"oral),":[816],"frequency":[817],"vaccination,":[819],"comparison":[827],"candidate":[829],"vaccines,":[830],"outlined.":[832],"These":[833],"variables":[834],"will":[835],"alone":[836],"represent":[837],"large":[840,888],"body":[841],"work.":[843],"High-tech":[844],"developed":[849],"down":[850],"road":[852],"prevent":[857],"emergence":[859],"pathogenic":[861],"against":[864],"escape,":[866],"perhaps":[868],"block":[871],"switch":[873],"from":[874,927],"CCR5":[875],"CXCR4":[877],"usage.":[878],"noted,":[881],"however,":[882],"still":[886,910],"gap":[889],"defined":[891],"markers":[893],"T-cell,":[896],"B":[897],"cell,":[898],"fact,":[903],"challenging":[908],"interesting":[912],"worthwhile":[914],"enterprise.":[915],"4":[917],"roundtable":[918],"conveners":[919],"\"Immunomodulators":[921],"2004:":[923],"Reality":[924],"Perspectives":[926],"Clinical":[929],"Point":[930],"View.\"":[932]},"counts_by_year":[],"updated_date":"2026-07-30T17:31:21.811387","created_date":"2021-02-15T00:00:00"}